fashion boutiques, jewelers, and antique shops nestled among the beckoning plazas and courtyards. Instantly amp up your island style at stores like the Old Naples Surf Shop and a Lilly Pulitzer ...
Lawyers for the board that awards Pulitzer Prizes asked a Florida state court to pause the defamation lawsuit President Trump filed against board members in 2022 until Trump is no longer president.
On Monday, the board that awards the Pulitzer Prizes — which Mr. Trump sued in Florida in 2022 for defamation — said that the case should be put on hold because, as Mr. Trump has argued in two ...
Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...
In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday woman: trailblazer Lilly Ledbetter, a pioneer from humble beginnings who took her employer ...
Unlike casual language learners — say, in a high school French class, or on Duolingo — for the characters in Sanaz Toossi’s Pulitzer-winning “English,” language acquisition feels imperative.
The Pulitzer Prize board is asking a judge to hit pause on a defamation case President Donald Trump filed against it until his presidency is over, using Trump’s own legal arguments against him.
A Trump-bashing, Pulitzer Prize-winning political cartoonist — whose illustrations have been published by the Washington Post, New Yorker and Los Angeles Times — was arrested for possession of ...
Get the best of Vancouver in your inbox, every Tuesday and Thursday. Sign up for our free newsletter. A Pulitzer-winning play is getting its Canadian premiere at the Arts Club’s Granville Island ...
Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.
Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...